Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-09 Purchase | 2025-04-11 9:57 pm | Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner | 934,258 | $10.13 | $9,464,512 | 5,446,072 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-16 Expired | 2025-06-12 4:51 pm | 2025-02-27 2025-05-16 | Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner | 1,314 | $0 | 0 (Indirect) | View |
| 2025-04-09 Other | 2025-04-11 9:57 pm | N/A N/A | Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner | 899,333 | $0 | 5,446,072 (Indirect) | View |
Ownership | 2025-04-11 8:58 pm | N/A N/A | Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner | 0 | $0 | 5,539,139 (Indirect) | View |
Ownership | 2021-05-06 8:41 pm | N/A N/A | Anebulo Pharmaceuticals Inc. | ANEB | Schneeberger Daniel Chief Executive Officer | 0 | $0 | 982,500 (Direct) | View |